03.Issue 04 april 23 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 10, Issue : 04, April – 2023

Title:

03.FORMULATION AND INVITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF DOMPERIDONE
‬

Authors :

N. Priyanka,* B. Rajamma, K. Narasimha, U. Neeraja, P. Anil Kumar, P. Bharathi, B. Ganga Ratnam

Abstract :

In the present work, an attempt has been made to develop controlled release tablets of Domperidone by selecting different grade of HPMC like HPMC K4 M, HPMC K15 M and Eudragit S-100 as retarding polymers. All the formulations were prepared by direct compression method. The blend of all the formulations showed god flow properties such as angle of repose, bulk density, tapped density. The prepared tablets were shown good post compression parameters and they passed all the quality control evaluation parameters as per I.P limits. Dissolution studies of Domperidone controlled release tablets in media with different dissolution media 0.1N HCl, Phosphate buffer pH (6.8) as per US Pharmacopoeia. The dissolution data revealed that the ratio of polymers is very important to achieve an optimum formulation. The formulation of Domperidone CR tablets shown that formulation F6 with HPMC K4 M (10mg) shown good drug release profile. Among all the formulations F6 formulation showed maximum % drug release i.e., 99.36% in 12 hours hence it is considered as optimized formulation F6 which contains HPMC K4 M (10mg).
Keywords: Domperidone, HPMC K4 M, HPMC K15 M, Eudragit S-100 and controlled release tablets.

Cite This Article:

Please cite this article in press N. Priyanka et al, Formulation And Invitro Evaluation Of Controlled Release Matrix Tablets Of Domperidone., Indo Am. J. P. Sci, 2023; 10 (04).

Number of Downloads : 10

References:

1. Sathish Ummadi, B. Shravani, N. G. Raghavendra Rao, M. Srikanth Reddy, B. Sanjeev Nayak. Overview on Controlled Release Dosage Form. International Journal of Pharma Sciences Vol. 3, No. 4 (2013): 258-269.
2. Brahmankar D.M. and Jaiswal S.B. (1995): “Biopharmaceutics and Pharmacokinetics” a Treatise. Vallabh Prakashan, First Edition; 336-337.
3. Lachman Leon, Lieberman Herbert A., Kanig Joseph L. (1996) “The theory and practice of industrial pharmacy” Second edition, Varghese publishing house; Bombay, 171-196.
4. Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: Pharmacokinetics. 2nd ed. Vallabh Prakashan, Delhi: 2009; 399-401.
5. John C, Morten C, The Science of Dosage Form Design, Aulton: Modified release peroral dosage forms. 2nd ed. Churchill Livingstone. 2002; 290-300.
6. Ali Nokhodchi, Shaista Raja, Pryia Patel, and Kofi Asare-Addo. The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems. Bioimpacts. 2012; 2(4): 175–187.
7. John C, Morten C, The Science of Dosage Form Design, Aulton: Modified release peroral dosage forms. 2nd ed. Churchill Livingstone. 2002; 290-300.
8. Sathish Ummadi, B. Shravani, N. G. Raghavendra Rao, M. Srikanth Reddy, B. Sanjeev Nayak. Overview on Controlled Release Dosage Form. International Journal of Pharma Sciences Vol. 3, No. 4 (2013): 258-269.
9. Vyas S,P, Khar RK.Controlled Drug delivery: Concepts and Advances .Concepts and Advances.1st ed.vallabh prakashan,2002,p,156-189.
10. Shargel L,Yu ABC. Modified release drug products. In:Applied Biopharmaceutics and Pharmacokinetics.4th ed.McGraw Hill.1999;169-171.
11. Welling P. G. and Dobrinska M. R., Dosing consideration and bioavailability assessment of controlled drug delivery system, Chapter 7, Controlled drug delivery; fundamentals and applications, 2nd edition, Robinson J.R. and Lee V. H. L. (Eds.), Marcel Dekker Inc., New York, 1978, 29,p. 254, 373.
12. Manisha Gahlyan, Saroj Jain. Oral Controlled Release Drug Delivery System- A Review.
13. Mamidala R, Ramana V, Lingam M, Gannu R, Rao MY. Review article factors influencing the design and performance of oral sustained/controlled release dosage form. Int. journal of pharmaceutical science and nanotechnology. 2009; 2:583.
14. Patel Nidh , Chaudhary Anamika, Soni Twinkle, Sambyal Mehul, Jain Hitesh,Upadhyay Umesh. Controlled Drug Delivery System: A Review. IAJPS 2016, 3 (3), 227-233.
15. Crank, J. (1975). The Mathematics of Diffusion. New York: Oxford Press.
16. Leon, L., & Herbert, L.A. (2002). Pharmaceutical Dosage Forms. New York: Marcel Dekker
17. Kar RK, Mohapatra S and Barik BB. Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Cli Res, 2009;2: 54.
18. Salsa T, Veiga F and Pina ME. Oral controlled release dosage form. I. Cellulose ether polymers in hydrophilic matrices. Drug Develop Ind Pharm,1997; 23: 929-938.
19. Kumar S, Shashikant and Bharat P. Sustained release drug delivery system: a review. Int J Inst Pharm Life Sci, 20122(3): 356-376.
20. Cristina M, Aranzaz;u Z and Jose ML. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Rel,2011; 154: 2011, 2-19.
21. Theeuwes, F. Elementary Osmotic Pump. J Pharm Sci, 1975;64, 1987–1991.

6. Jump up to:a b c “Oswald Schmiedeberg (1838-1921) Experimental Pharmacologist”. Journal of the American Medical Association. 204 (10): 924–925. 3 June 1968. doi:10.1001/jama.1968.03140230082018. ISSN 0098-7484. PMID 4869651.
7. Bäumer, Beatrix (2007). “Schmiedeberg, Oswald”. Neue Deutsche Biographie (in German). Vol. 23. pp. 227–228.
8. Jump up to:a b c d e Patil, Popat N. (2012). Discoveries in Pharmacological Sciences. Singapore: World Scientific. pp. 239–240. ISBN 978-981-4355-08-7
9. Waddington, Keir (2003). Medical education at St. Bartholomew’s hospital, 1123–1995. Boydell & Brewer. p. 123. ISBN 9780851159195. Retrieved 20 March 2016.
10. Jump up to:a b c d Feldberg, W. S. (1970). “Henry Hallett Dale. 1875–1968”. Biographical Memoirs of Fellows of the Royal Society. 16: 77–174. doi:10.1098/rsbm.1970.0006. PMID 11615480. S2CID 7383038.
11. Jump up to:a b Tansey, Elizabeth M. (1990). The early scientific career of Sir Henry Dale FRS (1875–1968). ucl.ac.uk (PhD thesis). University of London. OCLC 556469190. EThOS uk.bl.ethos.294137.
12. Halpern, B. (1969). “Obituary notice: Henry Hallet Dale”. Revue française d’allergologie. 9 (2): 117–119. doi:10.1016/s0370-4688(69)80008-6. PMID 4896522.
13. Yellapragada SubbaRao Archives OnLine. ysubbarao.info
14. Jadia, Varun (6 October 2016) Dr. Yellapragada Subbarao Revolutionised the Field of Medicine. The Better India.
15. Discoverer of miracle medicines – Y. Subba Rao (1895–1948). The Hindu (2003-03-13)
16. MycoBank, retrieved 26 December 2015
17. Hesseltine, C.W. (1953), “Study of Trickling Filter Fungi”, Bulletin of the Torrey Botanical Club, 80 (6): 507–514, doi:10.2307/2481965, JSTOR 2481965